triiodothyronine has been researched along with metoprolol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Feldt-Rasmussen, U; Hansen, JE; Hegedüs, L; Kayser, L; Perrild, H; Skovsted, L | 1 |
| Zierhut, W; Zimmer, HG | 1 |
| Angerås, U; Hasselgren, PO; Oldfors, A | 1 |
| Angerås, U; Hasselgren, PO; Jagenburg, R; Lindstedt, G | 1 |
| Angerås, U; Hasselgren, PO | 1 |
| Aoyagi, K; Baba, T; Ishizaki, T; Kitaoka, M; Kurimoto, F; Murabayashi, S; Nakazono, M; Sakurai, H; Takebe, K | 1 |
| Adlerberth, A; Hasselgren, PO; Jagenburg, R; Lindstedt, G; Stenström, G | 1 |
| Adlerberth, A; Angerås, U; Hasselgren, PO; Jagenburg, R; Lindstedt, G; Stenström, G | 1 |
| Angerås, U; Hasselgren, PO; Jagenburg, R | 1 |
| Anderberg, B; Kågedal, B; Karlberg, BE; Nilsson, OR | 1 |
| Christensen, LK; Hansen, JM; Perrild, H; Skovsted, L | 1 |
| Peele, ME; Shulkin, BL; Utiger, RD | 1 |
| Karlberg, BE; Nilsson, OR; Söderberg, A | 1 |
| Langlois, S; Lutterodt, A; Rangno, RE | 1 |
| Melander, A; Nilsson, OR; Tegler, L | 1 |
| Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
| Nakamura, S; Saio, Y; Suzuki, E | 1 |
| Gintautas, J; Maniar, R; Rao, S; Shikara, MM; Steier, W | 1 |
| Carrillo-Sepulveda, MA; Gerdes, AM; Li, Y; Ojamaa, K; Rajagopalan, V; Saini, AS; Tang, YD; Zhang, K; Zhang, Y | 1 |
| Bogush, N; Calvert, JW; Graham, RM; Husain, A; Naqvi, E; Naqvi, N; Tan, L; Taylor, WR | 1 |
1 review(s) available for triiodothyronine and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for triiodothyronine and metoprolol
| Article | Year |
|---|---|
The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Male; Metoprolol; Propranolol; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1991 |
Urinary excretion of 3-methylhistidine and creatinine and plasma concentrations of amino acids in hyperthyroid patients following preoperative treatment with antithyroid drug or beta-blocking agent: results from a prospective, randomized study.
Topics: Adult; Amino Acids; Creatinine; Female; Humans; Hyperthyroidism; Male; Methimazole; Methylhistidines; Metoprolol; Middle Aged; Preoperative Care; Prospective Studies; Proteins; Random Allocation; Thyroxine; Triiodothyronine | 1987 |
Cortisol, growth hormone and prolactin responses to insulin-induced hypoglycaemia in hyperthyroid patients before and during beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Female; Growth Hormone; Humans; Hydrocortisone; Hyperthyroidism; Hypoglycemia; Insulin; Male; Metoprolol; Middle Aged; Prolactin; Propranolol; Thyroxine; Triiodothyronine | 1980 |
Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.
Topics: Adult; Aged; Female; Heart Rate; Humans; Hyperthyroidism; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Triiodothyronine | 1980 |
The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hyperthyroidism; Male; Metoprolol; Middle Aged; Propranolol; Radioimmunoassay; Thyroxine; Triiodothyronine | 2003 |
17 other study(ies) available for triiodothyronine and metoprolol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Differential effects of triiodothyronine on rat left and right ventricular function and the influence of metoprolol.
Topics: Animals; DNA; Female; Heart Ventricles; Hemodynamics; Metoprolol; Organ Size; Rats; Rats, Inbred Strains; RNA; Triiodothyronine; Ventricular Function | 1989 |
The effect of beta-adrenergic blockade on the myopathic changes in experimental hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Hyperthyroidism; Male; Metoprolol; Microscopy, Electron; Muscles; Organ Size; Propranolol; Rats; Triiodothyronine | 1986 |
Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Histidine; Hyperthyroidism; Male; Methylhistidines; Metoprolol; Muscle Proteins; Propranolol; Rats; Triiodothyronine | 1987 |
Protein degradation in skeletal muscle during experimental hyperthyroidism in rats and the effect of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Hyperthyroidism; Male; Metoprolol; Muscle Proteins; Muscles; Propranolol; Rats; Rats, Inbred Strains; Triiodothyronine | 1987 |
Plasma renin activity, active and inactive renin concentrations, and their responses to beta 1-adrenoceptor blockade with metoprolol in hyperthyroidism.
Topics: Adult; Female; Humans; Hyperthyroidism; Male; Metoprolol; Receptors, Adrenergic, beta; Renin; Thyroxine; Triiodothyronine | 1986 |
Effects of thyroid hormone and beta-adrenoceptor blocking agents on urinary excretion of 3-methylhistidine and plasma amino acids in man.
Topics: Adult; Amino Acids; Female; Heart Rate; Histidine; Humans; Male; Methylhistidines; Metoprolol; Muscle Proteins; Propranolol; Triiodothyronine | 1986 |
Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats.
Topics: Amino Acids; Animals; Body Weight; Hyperthyroidism; Male; Metoprolol; Propranolol; Rats; Rats, Inbred Strains; Triiodothyronine | 1986 |
Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Humans; Hyperthyroidism; Metoprolol; Middle Aged; Propranolol; Sotalol; Triiodothyronine; Triiodothyronine, Reverse | 1983 |
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dithiothreitol; Liver; Male; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Timolol; Triiodothyronine | 1984 |
Plasma catecholamines and cardiovascular responses to hypoglycemia in hyperthyroidism before and during treatment with metoprolol or propranolol.
Topics: Adult; Epinephrine; Female; Goiter; Heart Rate; Humans; Hyperthyroidism; Hypoglycemia; Insulin; Kinetics; Male; Metoprolol; Middle Aged; Norepinephrine; Propanolamines; Propranolol; Reference Values; Thyroid Gland; Thyroxine; Triiodothyronine | 1980 |
Metoprolol withdrawal phenomena: mechanism and prevention.
Topics: Adult; Aged; Blood Pressure; Drug Administration Schedule; Epinephrine; Heart Rate; Humans; Isoproterenol; Male; Metoprolol; Middle Aged; Norepinephrine; Propanolamines; Substance Withdrawal Syndrome; Thyroxine; Triiodothyronine | 1982 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
Subacute thyroiditis with thyroid-stimulation blocking antibodies: a case report.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Autoantibodies; Benzopyrans; Female; HLA Antigens; Humans; Immunoglobulins, Thyroid-Stimulating; Iodine Radioisotopes; Metoprolol; Propionates; Receptors, Thyrotropin; Thyroid Gland; Thyroiditis, Subacute; Thyrotropin; Thyroxine; Triiodothyronine | 1996 |
Comparison of Therapeutic Triiodothyronine Versus Metoprolol in the Treatment of Myocardial Infarction in Rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Echocardiography; Electrophysiology; Female; Fibrosis; Heart Atria; Heart Ventricles; Hemodynamics; Inflammation; Metoprolol; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thyroid Hormones; Thyroxine; Triiodothyronine; Ventricular Function, Left | 2018 |
Remuscularization with triiodothyronine and β
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Metoprolol; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Triiodothyronine; Ventricular Dysfunction, Left; Ventricular Remodeling | 2022 |